Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The annotations already declare read-only, idempotent, open-world behavior. The description adds substantial behavioral context beyond those hints: internal cascading lookups replace 2-3 manual calls, identifiers are labeled by source, unresolved identifiers are explicitly listed, ambiguous matches return figi_candidates, and LEI/FIGI enrichment degrades gracefully when external sources are unavailable. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is densely packed and somewhat run-on, with large parentheticals that reduce scannability. However, each clause contributes useful information—supported identifiers, ambiguity behavior, graceful degradation—rather than filler. It is front-loaded with trigger phrases and the core purpose before expanding into detail.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite the absence of an output schema, the description covers what is returned: canonical identifiers, source labels, unresolved fields, figi_candidates on ambiguity, and RxCUI citations. It also explains fallback behavior if GLEIF/OpenFIGI are down. For a tool of this complexity, an agent has enough information to call it appropriately and interpret its results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is complete, but the description goes far beyond it: it documents ISIN as a valid company input, shows examples for each type, and warns about passing only the issuer name without trailing security-class words. It also clarifies that a non-ticker instrument can still resolve via name search, which meaningfully enriches the schema's bare parameter descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a precise verb-object pair: resolve a user-spoken name into canonical/official identifiers that other tools require. It enumerates supported types and concrete identifier examples (CIK, LEI, RxCUI, FIGI), and its 'Use FIRST whenever you have a name but need an ID' distinguishes it from downstream tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives strong when-to-use signals: explicit natural-language triggers and a direct 'Use FIRST' directive. It does not name an alternative tool explicitly or give a corresponding 'do not use if...' exclusion, but the context of being the pre-step to other tools requiring IDs is clear.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Several tools are easy to confuse: ask_pipeworx_beta is currently identical to ask_pipeworx, deep_research overlaps heavily with ask_pipeworx/ask_pipeworx_grounded, and the six polymarket_* tools have closely related purposes. ai_visibility_check and scan_competitor_ai_presence also overlap, making selection error-prone.

Naming Consistency4/5

Almost all tools use lowercase snake_case and mostly follow a verb_noun pattern (query_layer, resolve_entity, scan_dependency, validate_claim). A few noun-style names like entity_profile, layer_info, and pipeworx_trending deviate slightly, but the overall convention is predictable.

Tool Count2/5

34 tools is well past the heavy threshold, and the server is named 'Arcgis Charlotte' while only three tools actually relate to ArcGIS. The rest form a sprawling Pipeworx research, prediction-market, subscription, and memory toolkit, which creates a severe scope mismatch.

Completeness2/5

For the Pipeworx data side the surface is quite thorough, but for the declared ArcGIS Charlotte purpose it is thin: search_datasets, layer_info, and query_layer provide read-only access with no update/delete, analysis, or dataset management. The tool set therefore has a significant gap relative to its stated domain.